Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies

Stuart C. Gordon, Marlyn J. Mayo, Won Young Tak et al.|Unknown|2021

Cited by 0